What is the primary objective of FDA 21 CFR Part 11?

The primary objective of FDA 21 CFR Part 11 is to establish criteria under which the FDA considers electronic records and electronic signatures trustworthy, reliable, and equivalent to paper records and handwritten signatures executed on paper. Per §11.1(a), it ensures authenticity, integrity, and non-repudiation through controls like validation (§11.10(a)), audit trails (§11.10(e)), and signature linking (§11.70), applying to records created, modified, maintained, archived, retrieved, or transmitted under predicate rules.

Who is legally or professionally required to comply with FDA 21 CFR Part 11?

FDA 21 CFR Part 11 applies to any organization using electronic records or signatures in lieu of paper for predicate rule requirements, or relying on them for regulated activities. This includes pharmaceutical, biotech, medical device, and CRO/CMO firms under 21 CFR Parts 211, 820, or 58. Per §11.1(b), it covers electronic records submitted to FDA if accepted under docket 92S-0251; paper printouts relied upon as official records may exclude systems from scope, per 2003 guidance.

Does FDA 21 CFR Part 11 require an external audit or third-party certification?

No, FDA 21 CFR Part 11 does not require external audits or third-party certification. Compliance is demonstrated through internal validation, SOPs, and inspection readiness (§11.1(e)), with systems and documentation available for FDA review. The 2003 guidance emphasizes risk-based validation and predicate rule adherence over formal certification.

How often should an assessment for FDA 21 CFR Part 11 be performed?

FDA 21 CFR Part 11 assessments should be performed periodically as part of change control, system reviews, and risk reassessments, with no fixed frequency specified in the regulation. Align with predicate rules via ongoing validation lifecycle (§11.10(a)), periodic training (§11.10(i)), and documentation controls (§11.10(k)); conduct full reviews before major changes or annually for high-risk systems, per GAMP practices and 2003 guidance.

What are the consequences of non-compliance with FDA 21 CFR Part 11?

Non-compliance with FDA 21 CFR Part 11 can result in FDA Form 483 observations, warning letters, product holds, recalls, or injunctions, as predicate rules remain fully enforceable. The 2003 guidance notes continued enforcement of access controls (§11.10(d)), signatures (§§11.50-11.300), and data integrity failures, leading to violations like inadequate investigations or CAPA, as seen in enforcement actions.

Can FDA 21 CFR Part 11 be mapped to other international frameworks?

Yes, FDA 21 CFR Part 11 controls can be mapped to frameworks like EU Annex 11 for shared principles on validation, audit trails, and signatures, though Part 11 stands alone. Common mappings include closed/open system controls (§§11.10, 11.30) to Annex 11 risk-based approaches, but FDA's narrow scope and 2003 enforcement discretion require tailored alignment without cross-references in compliance documentation.

What is the first step to begin implementing FDA 21 CFR Part 11?

The first step to implement FDA 21 CFR Part 11 is to conduct a formal applicability assessment mapping predicate rules to electronic records and determining business reliance. Document scope decisions in SOPs (§11.1(b), 2003 guidance), classifying systems as closed (§11.3(b)(4)) or open (§11.3(b)(9)) to prioritize controls like access (§11.10(d)) and signatures (§11.100).

What is the primary objective of IEC 62443?

IEC 62443 defines requirements and processes for implementing and maintaining cybersecurity in Industrial Automation and Control Systems (IACS). The series establishes a shared-responsibility framework across asset owners, system integrators, and product suppliers, using risk-based zone/conduit segmentation and security levels (SL 0–4) to ensure reliability, integrity, and resilience against OT-specific threats.

Who is legally or professionally required to comply with IEC 62443?

IEC 62443 applies to asset owners, system integrators/service providers, and product suppliers managing IACS in sectors like energy, manufacturing, and utilities. As a horizontal standard recognized by IEC in 2021 and endorsed by UN/UNECE/NATO, it is professionally required for stakeholders handling IACS cybersecurity, with no universal legal mandate but frequent regulatory and contractual obligations.

Does IEC 62443 require an external audit or third-party certification?

IEC 62443 does not mandate external audits or third-party certification but supports them via ISASecure schemes. Modular certifications include SDLA (IEC 62443-4-1 secure development), CSA (IEC 62443-4-2 components), and SSA (IEC 62443-3-3 systems), enabling independent verification of maturity levels (ML1–ML4) and security levels.

How often should an assessment for IEC 62443 be performed?

IEC 62443 assessments should occur initially for baseline, then periodically via continuous improvement in the security program (IEC 62443-2-1). Risk assessments (IEC 62443-3-2) are performed at system design, changes, or threat evolution; ISASecure certifications require annual surveillance and triennial recertification.

What are the consequences of non-compliance with IEC 62443?

Non-compliance with IEC 62443 exposes organizations to operational disruptions, safety incidents, and regulatory/contractual penalties. Lacking zone/conduit protections and SL targets increases cyber risks in IACS, potentially causing downtime, equipment damage, or loss of critical infrastructure operations; no direct global fines, but sector regulations often reference it.

Can IEC 62443 be mapped to other international frameworks?

IEC 62443-2-1:2024 provides explicit mappings from Security Program Elements (SPE) to system requirements (SR) in 62443-3-3 and component requirements (CR) in 62443-4-2. These internal mappings support traceability; external mappings to other frameworks exist but are not defined within IEC 62443 itself.

What is the first step to begin implementing IEC 62443?

The first step is establishing governance via IEC 62443-2-1 by defining the IACS security program with roles, maturity levels (ML1–ML4), and asset inventory. This leads to scoping the System Under Consideration (SUC), initial zone/conduit modeling, and risk assessment per IEC 62443-3-2 to set Target Security Levels (SL-T).

Standards Comparison

FDA 21 CFR Part 11 vs IEC 62443

FDA 21 CFR Part 11

Mandatory

1997

FDA regulation for electronic records signatures equivalency

IEC 62443

Voluntary

2018

International standard for IACS cybersecurity frameworks.

Quick Verdict

FDA 21 CFR Part 11 ensures electronic records' trustworthiness for life sciences compliance, while IEC 62443 provides cybersecurity framework for industrial control systems. Companies adopt Part 11 for FDA enforcement; IEC 62443 for OT risk management and certification.

Electronic Records

FDA 21 CFR Part 11

21 CFR Part 11 Electronic Records; Electronic Signatures

Cost

€€€€

Complexity

Medium

Implementation Time

12-18 months

Key Features

Establishes equivalency for electronic records to paper
Mandates secure time-stamped audit trails
Differentiates controls for closed open systems
Requires unique non-repudiable electronic signatures
Applies risk-based predicate rule reliance scope

Industrial Cybersecurity

IEC 62443

IEC 62443: IACS Security Standards Series

Cost

€€€€

Complexity

Medium

Implementation Time

18-24 months

Key Features

Zones and conduits risk-based segmentation model
Security Levels SL-T, SL-C, SL-A triad
Shared responsibility across asset owners, suppliers, integrators
Seven Foundational Requirements FR1-7 for systems/components
ISASecure modular certifications SDLA, CSA, SSA

Detailed Analysis

A comprehensive look at the specific requirements, scope, and impact of each standard.

FDA 21 CFR Part 11 Details

What It Is

21 CFR Part 11 is a US FDA regulation defining criteria under which electronic records and electronic signatures are trustworthy, reliable, and equivalent to paper records and handwritten signatures. It targets FDA-regulated industries maintaining predicate-rule records electronically. Adopts a risk-based approach with narrow scope and enforcement discretion per 2003 guidance.

Key Components

Closed systems (§11.10): validation, audit trails, access limits, operational/authority/device checks, training, policies.
Open systems (§11.30): encryption, digital signatures added.
Signatures (Subparts B/C): manifestation (§11.50), linking (§11.70), uniqueness (§11.100), multi-component controls (§11.200/300). Built on predicate rules; focuses enforced core controls; compliance via validation and SOPs.

Why Organizations Use It

Meets legal obligations for pharma, devices, biologics.
Ensures data integrity, avoids enforcement actions.
Enables efficient paperless operations, inspection readiness.
Builds trust, accelerates digital transformation.

Implementation Overview

Phased risk-based: scope assessment, CSV (IQ/OQ/PQ), vendor governance, training. Applies to life sciences in US; verified via FDA inspections.

IEC 62443 Details

What It Is

IEC 62443 is the international consensus-based series of standards for securing Industrial Automation and Control Systems (IACS). It provides a comprehensive, risk-based framework spanning governance, risk assessment, system architecture, and component security across the full lifecycle.

Key Components

Four groupings: General (-1), Policies (-2), System (-3), Components (-4).
Seven Foundational Requirements (FR1-7) like authentication, integrity, and availability.
Zones/conduits model for segmentation; Security Levels (SL 0-4) with SL-T, SL-C, SL-A.
~140 component requirements; maturity levels ML1-4; ISASecure certifications (SDLA, CSA, SSA).

Why Organizations Use It

Mitigates OT risks in critical infrastructure (energy, manufacturing).
Enables shared responsibility among asset owners, integrators, suppliers.
Reduces downtime, supply chain risks; supports insurance, procurement.
Builds trust via certified assurance; horizontal applicability per IEC.

Implementation Overview

Phased: governance (2-1), risk assessment/zoning (3-2), requirements (3-3/4-2), certification. Applies to all IACS users globally; requires OT expertise, audits for maturity/certification. (178 words)

Key Differences

Aspect	FDA 21 CFR Part 11	IEC 62443
Scope	Electronic records/signatures trustworthiness	IACS cybersecurity across lifecycle
Industry	FDA-regulated life sciences	Industrial automation sectors globally
Nature	Mandatory US FDA regulation	Voluntary international standard
Testing	Risk-based system validation	Security level assessments/certification
Penalties	Warning letters, enforcement actions	No legal penalties, certification loss

Scope

FDA 21 CFR Part 11

Electronic records/signatures trustworthiness

IEC 62443

IACS cybersecurity across lifecycle

Industry

FDA 21 CFR Part 11

FDA-regulated life sciences

IEC 62443

Industrial automation sectors globally

Nature

FDA 21 CFR Part 11

Mandatory US FDA regulation

IEC 62443

Voluntary international standard

Testing

FDA 21 CFR Part 11

Risk-based system validation

IEC 62443

Security level assessments/certification

Penalties

FDA 21 CFR Part 11

Warning letters, enforcement actions

IEC 62443

No legal penalties, certification loss

Frequently Asked Questions

Common questions about FDA 21 CFR Part 11 and IEC 62443

FDA 21 CFR Part 11 FAQ

IEC 62443 FAQ

You Might also be Interested in These Articles...

NIST CSF 2.0 Supply Chain Risk Management: Complete Playbook with Profiles, Tiers, and Vendor Assessment Templates

Master NIST CSF 2.0 ID.SC supply chain risk management with vendor assessment templates, profile gap analysis, and tier strategies. Mitigate third-party threats

Beyond the Burden: How Intuitive Compliance Software Transforms Daily Workflows

Explore intuitive compliance software that automates workflows, simplifies onboarding, and reduces stress. Cut non-compliance costs 3x and boost efficiency for

The CIS Controls v8.1 Evidence Pack: What Auditors Ask For (and How to Produce Proof Fast)

Fail CIS Controls v8.1 audits due to missing evidence? Get the blueprint: exact artifacts auditors want, repository structure, and automation from security tool

Run Maturity Assessments with GRADUM

Transform your compliance journey with our AI-powered assessment platform

Assess your organization's maturity across multiple standards and regulations including ISO 27001, DORA, NIS2, NIST, GDPR, and hundreds more. Get actionable insights and track your progress with collaborative, AI-powered evaluations.

100+ Standards & Regulations

AI-Powered Insights

Collaborative Assessments

Actionable Recommendations

Explore More Comparisons

See how FDA 21 CFR Part 11 and IEC 62443 compare against other standards

Other FDA 21 CFR Part 11 Comparisons

Other IEC 62443 Comparisons

What It Is

Key Components

Closed systems (§11.10): validation, audit trails, access limits, operational/authority/device checks, training, policies.

Open systems (§11.30): encryption, digital signatures added.

Signatures (Subparts B/C): manifestation (§11.50), linking (§11.70), uniqueness (§11.100), multi-component controls (§11.200/300). Built on predicate rules; focuses enforced core controls; compliance via validation and SOPs.

Key Components

Four groupings: General (-1), Policies (-2), System (-3), Components (-4).

Seven Foundational Requirements (FR1-7) like authentication, integrity, and availability.

Zones/conduits model for segmentation; Security Levels (SL 0-4) with SL-T, SL-C, SL-A.

~140 component requirements; maturity levels ML1-4; ISASecure certifications (SDLA, CSA, SSA).

Aspect

FDA 21 CFR Part 11

IEC 62443

Scope

Electronic records/signatures trustworthiness

IACS cybersecurity across lifecycle

Industry

FDA-regulated life sciences

Industrial automation sectors globally

Nature

Mandatory US FDA regulation

Voluntary international standard

Testing

Risk-based system validation

Security level assessments/certification

Penalties

Warning letters, enforcement actions

No legal penalties, certification loss